amifostine anhydrous has been researched along with Parathyroid Neoplasms in 3 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Parathyroid Neoplasms: Tumors or cancer of the PARATHYROID GLANDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glover, DJ | 1 |
| Shaw, L | 1 |
| Glick, JH | 1 |
| Slatopolsky, E | 1 |
| Weiler, C | 1 |
| Attie, M | 1 |
| Goldfarb, S | 1 |
| Hirschel-Scholz, S | 2 |
| Jung, A | 1 |
| Fischer, JA | 1 |
| Trechsel, U | 1 |
| Bonjour, JP | 2 |
| Caverzasio, J | 1 |
1 review available for amifostine anhydrous and Parathyroid Neoplasms
| Article | Year |
|---|---|
Mechanism of the hypocalcemic agent WR-2721 and its acute and chronic application in eu- and hyperparathyroidism.
Topics: Amifostine; Animals; Bone Resorption; Humans; Hypercalcemia; Hyperparathyroidism; Magnesium; Organot | 1986 |
2 other studies available for amifostine anhydrous and Parathyroid Neoplasms
| Article | Year |
|---|---|
Treatment of hypercalcemia in parathyroid cancer with WR-2721, S-2-(3-aminopropylamino)ethyl-phosphorothioic acid.
Topics: Adenoma; Aged; Amifostine; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; H | 1985 |
Suppression of parathyroid secretion after administration of WR-2721 in a patient with parathyroid carcinoma.
Topics: Amifostine; Calcium; Cyclic AMP; Female; Humans; Hypercalcemia; Middle Aged; Organothiophosphorus Co | 1985 |